• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

143.30 +3.60 (+2.58%)
Streaming Delayed Price Updated: 1:33 PM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
Today 6:00 EDT
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
May 18, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)
May 15, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
May 13, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
April 29, 2026
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
April 27, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026
April 23, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio to Participate in Four Upcoming Investor Conferences
April 23, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th
April 22, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
April 21, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
March 31, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Participate in the Leerink Global Healthcare Conference
March 02, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
March 02, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
January 29, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
January 27, 2026
From Belite Bio, Inc
Via GlobeNewswire
InvestorNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs
December 05, 2025
Via Investor Brand Network
News headline image
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares
December 01, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
December 01, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease
December 01, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 10, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
November 05, 2025
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
November 03, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
October 31, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
October 30, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 4th
October 29, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences; Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference
October 29, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Participate in the 2025 Maxim Growth Summit
October 16, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
October 15, 2025
From Belite Bio, Inc
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap